Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratympanic Injections”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Study completedNCT02265393
What this trial is testing

A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom

Who this might be right for
Meniere's Disease
Otonomy, Inc. 128
Testing effectiveness (Phase 2)Ended earlyNCT02740387
What this trial is testing

Open Label Study of OTO-104 in Subjects With Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07404709
What this trial is testing

Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss

Who this might be right for
Sudden Hearing LossExtracellular Vesicles
The Affiliated Hospital of Qingdao University 9
Early research (Phase 1)Study completedNCT04601909
What this trial is testing

FX-322 in Adults With Age-Related Sensorineural Hearing Loss

Who this might be right for
PresbycusisHearing Loss, SensorineuralNoise Induced Hearing Loss+1 more
Frequency Therapeutics 30
Early research (Phase 1)Study completedNCT04629664
What this trial is testing

FX-322 in Adults With Severe Sensorineural Hearing Loss

Who this might be right for
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Frequency Therapeutics 31
Large-scale testing (Phase 3)Ended earlyNCT02768662
What this trial is testing

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 142
Testing effectiveness (Phase 2)Study completedNCT04829214
What this trial is testing

OTO-313 in Subjects With Unilateral Subjective Tinnitus

Who this might be right for
Subjective Tinnitus
Otonomy, Inc. 153
Large-scale testing (Phase 3)Ended earlyNCT02706730
What this trial is testing

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 189
Not applicableStudy completedNCT06885723
What this trial is testing

Use of Vibration Anesthesia Device in Intratympanic Injections

Who this might be right for
Intratympanic InjectionsSudden Hearing Loss
Yuzuncu Yil University 40
Testing effectiveness (Phase 2)UnknownNCT01108601
What this trial is testing

Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity

Who this might be right for
Hearing Loss
McGill University Health Centre/Research Institute of the McGill University Health Centre 20
Large-scale testing (Phase 3)Looking for participantsNCT05851508
What this trial is testing

The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease

Who this might be right for
Meniere Disease
Leiden University Medical Center 148
Early research (Phase 1)Study completedNCT01084525
What this trial is testing

OTO-104 for Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 44
Very early researchUnknownNCT04794842
What this trial is testing

Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection

Who this might be right for
Intratympanic Steroid InjectionIdiopathic Sudden Sensorineural Hearing LossMeniere Disease
Our Lady of the Lake Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT01526174
What this trial is testing

Intratympanic Injection for Autoimmune Inner Ear Disease

Who this might be right for
Autoimmune Inner Ear Disease
House Research Institute 16
Early research (Phase 1)Study completedNCT01755286
What this trial is testing

OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement

Who this might be right for
Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement
Otonomy, Inc. 83
Testing effectiveness (Phase 2)Study completedNCT04120116
What this trial is testing

FX-322 in Adults With Stable Sensorineural Hearing Loss

Who this might be right for
Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss
Frequency Therapeutics 95
Large-scale testing (Phase 3)Study completedNCT03508440
What this trial is testing

Intratympanic Steroid for Bell's Palsy

Who this might be right for
Bell's PalsyFacial Nerve Paresis
University of Missouri-Columbia 10
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Not applicableNot Yet RecruitingNCT06213415
What this trial is testing

Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

Who this might be right for
Bell Palsy
Assiut University 42
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Load More Results